Fundraising FoxAlta Partners — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtechSan Carlos, US
Anthony Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Henry Skinner(Director)Liam Ratcliffe(Director)in
BoardRon Hunt(Director)inLoretta Tse, Ph.D.(Director)
Co-investorsLongitude CapitalJohnson & Johnson Innovation – JJDCNew Leaf Venture PartnersPappas CapitalChiesi VenturesPappas Capital
Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Hugo Peris(Founder and Chief Executive Officer)inEugene de Juan(Executive Officer, Director)Lawrence Fritz(Director)
BoardWARREN THALER(Director)JEAN-FREDERIC PAULSEN(Director)
Board seatGuy Nohra· per SEC Form D · $10.9M raise · filed Feb 2023
Co-investorsCatalio Capital ManagementInveready Technology Investment GroupLifelinkStartXCamden PartnersEsperante Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.